For citations:
Safina S.Z., Varlamov S.A., Snegovoy A.V., Varlamov I.S., Gurina L.I., Manzuk L.V., Tsimafeyeu I.V. Five-year overall survival of metastatic renal cell carcinoma patients treated with everolimus after progression on bevacizumab: a prospective multicenter study CRAD001LRU02T. Cancer Urology. 2017;13(4):40-44. (In Russ.) https://doi.org/10.17650/1726-9776-2017-13-4-40-44
Email this article 